title: FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis.
authors.forename: M
authors.initials: M
authors.lastname: Maeder-Ingvar
authors.forename: J O
authors.initials: JO
authors.lastname: Prior
authors.forename: S R
authors.initials: SR
authors.lastname: Irani
authors.forename: V
authors.initials: V
authors.lastname: Rey
authors.forename: A
authors.initials: A
authors.lastname: Vincent
authors.forename: A O
authors.initials: AO
authors.lastname: Rossetti
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001479:Basal Ganglia / Q000000981:diagnostic imaging*; D001921:Brain / Q000000981:diagnostic imaging; D004569:Electroencephalography; D004660:Encephalitis / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000276:immunology; D017029:Epilepsy, Complex Partial / Q000150:complications / Q000000981:diagnostic imaging; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007806:Language Disorders / Q000150:complications / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*
chemical_list: D000927:Anticonvulsants; D019275:Radiopharmaceuticals; D016194:Receptors, N-Methyl-D-Aspartate; D019788:Fluorodeoxyglucose F18